A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection.

BACKGROUND Highly pathogenic H5N1 avian influenza viruses continue to spread via waterfowl, causing lethal infections in humans. Vaccines can prevent the morbidity and mortality associated with pandemic influenza isolates. Predicting the specific isolate that may emerge from the 10 different H5N1 clades is a tremendous challenge for vaccine design. METHODS In this study, we generated a synthetic hemagglutinin (HA) on the basis of a new method, computationally optimized broadly reactive antigen (COBRA), which uses worldwide sequencing and surveillance efforts that are specifically focused on sequences from H5N1 clade 2 human isolates. RESULTS Cynomolgus macaques vaccinated with COBRA clade 2 HA H5N1 virus-like particles (VLPs) had hemagglutination-inhibition antibody titers that recognized a broader number of representative isolates from divergent clades as compared to nonhuman primates vaccinated with clade 2.2 HA VLPs. Furthermore, all vaccinated animals were protected from A/Whooper Swan/Mongolia/244/2005 (WS/05) clade 2.2 challenge, with no virus detected in the nasal or tracheal washes. However, COBRA VLP-vaccinated nonhuman primates had reduced lung inflammation and pathologic effects as compared to those that received WS/05 VLP vaccines. CONCLUSIONS The COBRA clade 2 HA H5N1 VLP elicits broad humoral immunity against multiple H5N1 isolates from different clades. In addition, the COBRA VLP vaccine is more effective than a homologous vaccine against a highly pathogenic avian influenza virus challenge.

[1]  F. Conraths,et al.  Phylogenetic analyses of highly pathogenic avian influenza virus isolates from Germany in 2006 and 2007 suggest at least three separate introductions of H5N1 virus. , 2008, Veterinary microbiology.

[2]  John Steel,et al.  Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain , 2010, mBio.

[3]  C. Gomersall,et al.  Avian influenza (H5N1): implications for intensive care , 2006, Intensive Care Medicine.

[4]  N. Cox,et al.  Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. , 1998, Science.

[5]  Xinxia Peng,et al.  Lethal Influenza Virus Infection in Macaques Is Associated with Early Dysregulation of Inflammatory Related Genes , 2009, PLoS pathogens.

[6]  Feng Gao,et al.  Cross-Subtype T-Cell Immune Responses Induced by a Human Immunodeficiency Virus Type 1 Group M Consensus Env Immunogen , 2006, Journal of Virology.

[7]  S. Salzberg,et al.  Genome Analysis Linking Recent European and African Influenza (H5N1) Viruses , 2007, Emerging infectious diseases.

[8]  J. Kwang,et al.  Neutralizing Epitopes of Influenza Virus Hemagglutinin: Target for the Development of a Universal Vaccine against H5N1 Lineages , 2010, Journal of Virology.

[9]  T. Tumpey,et al.  Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets. , 2011, Vaccine.

[10]  D. Weiner,et al.  Immunogenicity of novel consensus-based DNA vaccines against avian influenza. , 2007, Vaccine.

[11]  Gavin J. D. Smith,et al.  Feasibility of reconstructed ancestral H5N1 influenza viruses for cross-clade protective vaccine development , 2010, Proceedings of the National Academy of Sciences.

[12]  R. Webster,et al.  Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets. , 2006, The Journal of infectious diseases.

[13]  N. Sardesai,et al.  Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus. , 2008, Vaccine.

[14]  Yan Li,et al.  Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus , 2007, Nature.

[15]  T. Kuiken,et al.  Pathology of Human Influenza A (H5N1) Virus Infection in Cynomolgus Macaques (Macaca fascicularis) , 2003, Veterinary pathology.

[16]  T. Kuiken,et al.  Pathogenesis of Influenza A (H5N1) Virus Infection in a Primate Model , 2001, Journal of Virology.

[17]  T. Ross,et al.  Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. , 2007, Vaccine.

[18]  T. Tatusova,et al.  The Influenza Virus Resource at the National Center for Biotechnology Information , 2007, Journal of Virology.

[19]  D. Weiner,et al.  Electroporation of Synthetic DNA Antigens Offers Protection in Nonhuman Primates Challenged with Highly Pathogenic Avian Influenza Virus , 2009, Journal of Virology.

[20]  A. S. Beare.  Basic and applied influenza research , 1982 .

[21]  T. Ross,et al.  Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines. , 2009, Vaccine.

[22]  K. Subbarao,et al.  Attacking the flu: Neutralizing antibodies may lead to 'universal' vaccine , 2009, Nature Medicine.

[23]  C. Macken,et al.  Phylogenetic characterization of H5N1 avian influenza viruses isolated in Indonesia from 2003-2007. , 2009, Virology.

[24]  C. Sandrock,et al.  Avian Influenza: Update , 2010, Medical Principles and Practice.

[25]  D. Ho,et al.  A consensus–hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses , 2008, Proceedings of the National Academy of Sciences.

[26]  Keiji Fukuda,et al.  Detection of Antibody to Avian Influenza A (H5N1) Virus in Human Serum by Using a Combination of Serologic Assays , 1999, Journal of Clinical Microbiology.

[27]  R. Webster,et al.  Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. , 2006, The Journal of infectious diseases.

[28]  J. Lifson,et al.  Macrophages relate presynaptic and postsynaptic damage in simian immunodeficiency virus encephalitis. , 2002, The American journal of pathology.

[29]  T. Ross,et al.  Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins. , 2003, Vaccine.

[30]  T. Kuiken,et al.  A Primate Model to Study the Pathogenesis of Influenza A (H5N1) Virus Infection , 2003, Avian diseases.

[31]  K. Subbarao,et al.  Emerging Respiratory Viruses: Challenges and Vaccine Strategies , 2006, Clinical Microbiology Reviews.

[32]  Carole R. Baskin,et al.  Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus , 2009, Proceedings of the National Academy of Sciences.

[33]  J. Baker,et al.  Intranasal Immunization of Ferrets with Commercial Trivalent Influenza Vaccines Formulated in a Nanoemulsion-Based Adjuvant , 2011, Clinical and Vaccine Immunology.

[34]  T. Tumpey,et al.  Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes. , 2011, Vaccine.

[35]  T. Ross,et al.  computationally optimized broadly reactive antigen ( COBRA ) based H 5 N 1 VLP accine elicits broadly reactive antibodies in mice and ferrets , 2011 .

[36]  Jean-Michel Claverie,et al.  Phylogeny.fr: robust phylogenetic analysis for the non-specialist , 2008, Nucleic Acids Res..

[37]  Y. Kawaoka,et al.  Immunogenicity and Protective Efficacy of a Live Attenuated H5N1 Vaccine in Nonhuman Primates , 2009, PLoS pathogens.

[38]  György Czifra,et al.  Molecular characterization of highly pathogenic H5N1 avian influenza viruses isolated in Sweden in 2006 , 2008, Virology Journal.

[39]  Ying-hua Chen,et al.  Characterization of immunity induced by M2e of influenza virus. , 2007, Vaccine.

[40]  M. Imai,et al.  Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model. , 2007, Vaccine.

[41]  T. Reinhart,et al.  Improved detection of simian immunodeficiency virus RNA by in situ hybridization in fixed tissue sections: combined effects of temperatures for tissue fixation and probe hybridization. , 2002, Journal of virological methods.

[42]  A. Osterhaus,et al.  Molecular and antigenic evolution and geographical spread of H5N1 highly pathogenic avian influenza viruses in western Africa. , 2007, The Journal of general virology.

[43]  M. Ramanathan,et al.  Enhanced cellular immune responses elicited by an engineered HIV-1 subtype B consensus-based envelope DNA vaccine. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[44]  T. Tumpey,et al.  Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle , 2008, PloS one.